Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells

Experimental and Toxicologic Pathology

Volumn 63, Issue 1-2, 2011, Pages 167-173

  Parekh, Palak ^a   Motiwale, Leena ^a,c   Naik, Nishigandha ^b,c   Rao, K V K ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b CANCER RESEARCH INSTITUTE   (India)

^c Piramal Enterprises Limited   (India)

Author keywords

Akt and Pak1 kinase; Cyclin D1; MAP kinases; Resveratrol

Indexed keywords

CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE P38; P21 ACTIVATED KINASE 1; PROTEIN KINASE B; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL SURVIVAL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LIVER CANCER; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION;

ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN D1; DOWN-REGULATION; FLOW CYTOMETRY; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MICROSCOPY, CONFOCAL; P21-ACTIVATED KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STILBENES;

EID: 78650173217     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.11.005     Document Type: Article

References (32)

1. Ahmad N., Adhami V.M., Afaq F., Feyes D.K., Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001, 7:1466-1473.
2. Balasenthil S., Sahin A.A., Barnes C.J., Wang R.G., Pestell R.K., Vadlamudi Kumar R. p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J Biol Chem 2004, 279:1422-1428.
3. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1978, 47:936-942.
4. Cichewicz R.H., Kouzi S.A. Resveratrol oligomers: structure, chemistry, and biological activity. J. Nat Prod Chem 2002, 26:507-579.
5. Delmas D., Jannin B., Malki M.C., Latruffe N. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol Rep 2000, 7:847-852.
6. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthetase kinase-3Β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998, 12:3499-3511.
7. Fontecave M., Lepoive M., Elleingands E., Gerez C., Guittet O. Resveratrol a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998, 421:277-279.
8. Gonzalez F.A., Seth A., Raden D.L., Bowman D.S., Fay F.S., Davis R.J. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol 1993, 122:1089-1101.
9. Gusman J., Malonne H., Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 2001, 22:1111-1117.
10. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive cactivity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
11. Kundu J.K., Surh Y.-J. Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets. Mutat Res 2004, 555:65-80.
12. Kundu J.K., Chun K.S., Kim S.O., Surh Y.J. Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular tagets. Biofactors 2004, 21:33-39.
13. Kuo P.L., Chiang L.C., Lin C.C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 2002, 72:23-34.
14. Lavoie J.N., Rivard N., L'Allemain G., Pouyssegur J. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog. Cell Cycle Res 1996, 2:49-58.
15. Lee S.K., Mbwambo Z.H., Chung H., Luyengi L., Gamez E.J., Mehta R.G., et al. Evaluation of the antioxidant potential of natural products. Comb Chem High Throughput Screen 1998, 1:35-46.
16. Mirza A.M., Gysin S., Malek N., Nakayama K., Robers J.M., McMahon M. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT. Mol Cell Biol 2004, 24:10868-10881.
17. Nheu T., He H., Hirokawa Y., Walker F., Wood J., Maruta H. PAK is essential for RAS-induced upregulation of cyclin D1 during the G1 to S transition. Cell Cycle 2004, 3:71-74.
18. Ono K., Han J. The p38 signal transduction pathway activation and function. Cell Signal 2000, 12:1-13.
19. Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 1999, 19:235-242.
20. Parekh P., Rao K.V.K. Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive carcinogenesis. Cell Biol Int 2007, 31:35-43.
21. Pozo-Guisada E., Lorenzo-Benavas M.J., Fernandez-Salguero P.M. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 2004, 109:167-173.
22. Reagan-Shaw S., Afaqu F., Aziz M.H., Ahmad N. Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 2004, 23:5151-5160.
23. She Q.B., Bode A.M., Ma W.Y., Chen N.Y., Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 2001, 61:1604-1610.
24. Shih A., Davis F.B., Lin H.Y., Davis P.J. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab 2002, 87:1223-1232.
25. Shimizu T., Nakazato T., Xian M.J., Sagawa M., Ikeda Y., Kizaki M. Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochem Pharmacol 2006, 71:742-750.
26. Sun Z.-J., Pen C.-E., Liu H.-S., Wang G.-J. Anti-hepatoma activity of resveratrol in vitro. World J. Gatroenterol 2002, 8:79-81.
27. Sundarajan M., Fernandis A.Z., Subrahmanyam G., Prabhudesai S., Krishnamurthy S.C. Rao KVK. Enhanced sequential expression of G1/S cyclins during experimental hepatocarcinogenesis and tyrosine phosphorylation. J Environ Pathol Toxicol Oncol 2001, 20:189-197.
28. Sundarajan M., Gupta S., Rao K.V.K. Overexpression of cyclin D1 is associated with the decondensation of chromatin during DEN-induced hepatocarcinogenesis. Cell Biol Int 2002, 26:699-706.
29. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
30. Vastano B.C., Chen Y., Zhu N., Ho C.T., Zhou Z., Rosen R.T. Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. J Agric Food Chem 2000, 48:253-256.
31. Wolter F., Akoglu B., Claustnitzer A., Stein J. Downregulation of the cyclinD1/Cdk4 complex occurs during resveratrol induced cell cycle arrest in colon cancer cell lines. J Nutr 2001, 131:2197-2203.
32. Yu L., Sun Z.J., Wu S.L., Pan C.E. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J Gastroenterol 2003, 9:2341-2343.